Vigilant Biosciences' Series B - II Round

Vigilant Biosciences raised a round of funding on October 27, 2015.

Vigilant Biosciences develops solutions that aid clinicians in the early detection and intervention of cancer. The Vigilant Biosciences OncAlert Oral Cancer product line and OncAlert Labs product line…

Articles about Vigilant Biosciences' Series B - II Round: